Insulin-like growth factor II receptors in human brain and their absence in astrogliotic plaques in multiple sclerosis by Wilczak, N et al.
  
 University of Groningen
Insulin-like growth factor II receptors in human brain and their absence in astrogliotic plaques
in multiple sclerosis





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2000
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Wilczak, N., De Bleser, P., Luiten, P., Geerts, A., Teelken, A., & De Keyser, J. (2000). Insulin-like growth
factor II receptors in human brain and their absence in astrogliotic plaques in multiple sclerosis. Brain-
research, 863(1-2), 282-288. https://doi.org/10.1016/S0006-8993(00)02153-3
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Brain Research 863 (2000) 282–288
www.elsevier.com/ locate /bres
Short communication
Insulin-like growth factor II receptors in human brain and their
absence in astrogliotic plaques in multiple sclerosis
a , b c c a*Nadine Wilczak , Pieter De Bleser , Paul Luiten , Albert Geerts , Albert Teelken ,
aJacques De Keyser
aDepartment of Neurology, Academisch Ziekenhuis Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands
bLaboratory for Cell Biology and Histology, Vrije Universiteit Brussel, Brussels, Belgium
cDepartment of Animal Physiology, Rijksuniversiteit Groningen, Haren, The Netherlands
Accepted 7 February 2000
Abstract
125Insulin-like growth factor (IGF) II receptors were studied in human adult brain by using autoradiography with [ I]IGF-II. Receptors
were found to be widely distributed throughout all neuronal regions. The highest densities were found in plexus choroideus, granular layer
of the cerebellar cortex, gyrus dendatus and pyramidal layer of the hippocampus, striatum, and cerebral cortex. White matter was devoid
125
of IGF-II receptors. We also examined [ I]IGF-II binding in six plaques of multiple sclerosis, which were characterized by a dense
network of astrocytes. We were unable to detect IGF-II receptors in any of the astrogliotic plaques, suggesting that IGF-II receptors in
human brain are not involved in astrogliosis. The regional variations in neuronal distribution of IGF-II receptors suggest involvement of
IGF-II in functions associated with specific neuronal pathways. Ó 2000 Elsevier Science B.V. All rights reserved.
Themes: Development and egeneration
Topics: Neurotrophic factors: receptors and cellular mechanism
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The insulin-like growth factors (IGFs), IGF-I and IGF- in the central nervous system in both rodents [3,11,16] and
II, are mitogenic polypeptides with structural homology to humans [1,7]. The distribution of IGF-II receptors has been
insulin. Two major types of receptors recognize the IGFs investigated in rodent brain [11,16,20]. However, there is
and mediate their physiological effects: IGF-I and IGF-II only one report dealing with the presence of IGF-II
receptors [6,8,9]. The IGF-I receptor is a heterotetrameric binding sites in brain homogenates from a single individual
glycoprotein composed of two a and two b subunits linked [19]. Here we present the first autoradiographic study in
by disulfide bounds [6]. The IGF-II receptor is a mono- human brain.
meric receptor with a striking extracellular domain made Brain tissue was obtained at autopsy from six patients
up almost exclusively of 15 cysteine-based repeats, and is (three females and three males), aged 65–78 years, who
identical to the cation-independent mannose-6-phosphate had died without evidence of neurologic or psychiatric
receptor [14,18]. In fact, these receptors display two disease. Slices of hemispheric white matter containing
distinctive binding sites: one for IGF-II and another for chronic plaques with dense astrogliosis, identified by glial
mannose-6-phosphate containing glycoproteins, which are fibrillary acidic protein (GFAP) immunoperoxidase stain-
mainly lysosomal enzymes that are endocytosed into ing, were obtained from four patients with multiple
endosomes. IGF-I receptors have been studied extensively sclerosis (three females and one male; aged 59–78 years).
Post-mortem delay ranged between 4 and 12 h. Tissue
blocks of 0.5-cm thick were frozen rapidly by immersion
in isopenthane–dry-ice or liquid nitrogen, and stored at
*Corresponding author. Tel.: 131-50-361-2430; fax: 131-50-361-
2808C until further processing.1707.
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coated with embedding medium and sections of 15-mm
thickness were cut at 2208C using a microtome-cryostat,
mounted on gelatin-coated glass slides.
Sections were preincubated for 15 min at 208C in 25
mM Tris–HCl (pH 7.4), containing 10 mM MgCl , and2
0.1% bovine serum albumin. Incubation experiments with
125[ I]IGF-II (specific activity 2000 Ci /mmol; Amersham,
UK) were done in duplicate at 208C in the same buffer
composition. For saturation and competition binding
studies the sections were incubated for 120 min with
125[ I]IGF-II. For saturation binding experiments nine con-
125
centrations of [ I]IGF-II between 0.01 and 2 nM were
used. Competition binding experiments with IGF-I and
IGF-II were done with a concentration of 0.1 nM
125[ I]IGF-II. After incubation, the sections were washed in
ice-cold buffer to remove unbound ligand, wiped from the
slides with Whatman GF/B glass fiber filters, and radioac-
tivity was determined in a gamma-counter. Binding iso-
therms were analyzed by non-linear least-square curve
Fig. 1. Representative competition curves for IGF-II (s) and IGF-I (d)fitting. K values were calculated from analysis of theD 125inhibition of 0.1 nM [ I]IGF-II specific binding on microtome sectionsScatchard plots. The dissociation constants (K values) ofi of cerebellum. Computer analysis of the binding data revealed that theIGI-I and IGF-II (Gropep, Australia) were calculated from
competition curves were best described by a one-component binding
the corresponding IC values according to the equation of model.50
Cheng and Prusoff [4]. Non-specific binding was obtained
in the presence of 0.5 mM IGF-II. Specific binding was
obtained by subtracting non-specific binding from the total II were best fitted to a one-site binding model (Fig. 1). The
binding. calculated K value (mean6S.E.M., n53) was 2.460.3 nMi
For autoradiography, the sections were dried under a for IGF-II and 25.662.1 nM for IGF-I. The brain also
stream of cold air, placed in X-ray cassettes together with contains IGFBPs, of which at least six types have been
125 3[ I]standards (Amersham), and apposed to [ H]Ultrofilm identified. These proteins can bind both IGF-I and IGF-II,
(Amersham) for 4 days and analyzed as described previ- and regulate their access to the IGF receptors [2,5,6,9]. By
ously [7]. The regions of interest were sampled and mean using immunocytochemistry on unwashed slices of frontal
optical densities determined, and converted into fmol /mg cortex we were able to identify IGFBPs 1, 2, 3, 5 and 6 on
protein, based on the experimentally determined relation neuronal cell bodies. However, after preincubating the
between polymer and brain paste standards (kindly pro- slices for 15 min at 208C in the same buffer used by
vided by Amersham, UK). autoradiographic experiments, IGFBPs were no longer
For immunocytochemistry sections were fixed in 3% detectable in the slices (Fig. 2). Thus, IGFBPs were
paraformaldehyde in 0.01 M phosphate buffered saline removed from the tissue slices during the preincubation
(PBS) for 15 min at room temperature and three times procedure, indicating that in the experimental conditions
125
washed with PBS for 5 min. After blocking of non-specific that we used [ I]IGF-II binding occurred to IGF-II
background staining with 5% normal goat serum, the receptors.
avidin–biotin–peroxidase complex was used. Sections Similar to rodent brain [11,16,17,20], IGF-II receptors
were incubated in primary antibody solution (1 /200) goat- were found to be widely expressed throughout the neuronal
anti-insulin-like growth factor binding proteins (IGFBPs) regions of the human brain. The regional distribution of the
1, 2, 3, 5 and 6 (Gropep) in PBS, overnight at 48C. The IGF-II receptors is shown in Table 1. Representative
secondary antibody was biotinylated, sections were incu- autoradiographs are shown in Figs. 3 and 4. The highest
bated for 90 min at room temperature in rabbit-anti-goat density was observed in choroid plexus. Relatively high
(1 /200) solution. Finally the sections were incubated in levels of IGF-II receptors were found in the different
horseradish peroxidase-conjugated streptavidin in PBS for layers of the cerebral cortex and in the neostriatum
90 min at room temperature and processed by the (caudate nucleus, putamen, and accumbens nucleus). In the
diaminobenzidine (DAB)/H O reaction. Between all hippocampal formation, IGF-II receptors were concen-2 2
steps the sections were rinsed thoroughly with PBS. trated in the granular layer of the dentate gyrus and the
125The binding of [ I]IGF-II to human cerebellum was pyramidal layers of the CA1–CA3 subfields. In the
saturable. Scatchard analysis of the saturation binding data cerebellar cortex, highest labeling was observed in the
revealed a K value (mean6S.E.M., n53) of 0.7960.06 granular layer and low levels were seen in the molecularD
nM (not shown). Competition curves with IGF-I and IGF- layer. In the midbrain, IGF-II receptors were mainly
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Fig. 2. Immunocytochemistry with anti-IGFBP-3 in non-preincubated (A) and preincubated (B) slices of frontal cortex. IGFBP-3 is located on neuronal
cell bodies (arrows). After preincubation for 15 min at 208C in 25 mM Tris–HCl (pH 7.4), containing 10 mM MgCl , and 0.1% bovine serum albumin,2
IGFBP-3 is no longer detectable. Bar550 mm.
detected in substantia nigra and periaquaductal gray. Low whereas IGF-I receptors predominate in the molecular cell
binding was also observed in the red nucleus. In the pons layer [7].
moderate levels of IGF-II receptors were associated with The finding that discrete neuronal regions contain higher
the pontine nuclei. Moderate levels of IGF-II receptors levels of IGF-II receptors may suggest a more specialized
were also observed in the pallidium, amygdala, and role of IGF-II as trophic / survival factor or perhaps as
thalamus. We found no IGF-II receptors in the white neuromodulator for well-defined neuronal systems. The
matter. In many brain areas, such as the striatum, cerebral role of the IGF-II receptors in the different neuronal
cortex, and hippocampus, the distribution pattern of IGF-II regions is not well understood. In vitro, IGF-II mimics the
receptors is comparable to that of IGF-I receptors [7]. The mitogenic actions of IGF-I, through stimulation of IGF-I
most striking difference is that in the cerebellar cortex receptors [6,15]. In human brain IGF-I has a ten times
highest labeling was observed in the granular cell layer, higher affinity than IGF-II for the IGF-I receptor [7]. On
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Table 1
aRegional distribution of IGF-II receptors in human brain
Region Receptor concentration in fmol /mg protein
(mean6S.E.M.)
Frontal, parietal, occipital,
and temporal cortex 2967
Cerebral white matter ND
Corpus callosum ND



















a Data were generated in brain samples from six individuals. ND, not detectable.
the other hand, we found in this study that IGF-II was ten Chronic plaques of multiple sclerosis were identified by
125times more potent than IGF-I in displacing [ I]IGF-II. myelin staining (Fig. 4). The plaques contained a dense
These findings indicate that in human brain, under physio- atrogliosis as visualized by GFAP immunochemistry (not
logical conditions, IGF-I preferentially interacts with IGF-I shown). Similar to normal appearing white matter, we
125
receptors, and IGF-II with IGF-II receptors. In vitro could not detect specific binding of [ I]IGF-II to IGF-II
observations suggest that IGF-II receptors may function in receptors in any of these plaques. IGF-II receptor con-
diverse biologic processes. IGF-II may act as a modulator centrations in cerebral cortex of MS patients (3163 fmol /
for the trafficking of mannose-6-phosphate bearing mg protein) were not significantly different from those in
lysosomal enzymes into the cell [11,14,18]. Binding of controls (2967 fmol /mg protein; Mann–Whitney test). It
IGF-II to its receptor may also activate a signaling has previously been reported that IGF-I receptors are
mechanism through interaction with a GTP-binding protein present in white matter and astrogliotic plaques from
[5,14], the physiological role of which is not yet under- patients with multiple sclerosis, which is consistent with a
stood. Konishi et al. [13] found that IGF-II enhanced well-recognized role of IGF-I in oligodendrocyte survival,
choline acetyltransferase activity in a dose-dependent myelination, and stimulation of astrocytes [21]. The ab-
manner in cultures of embryonic mouse septal neurons. sence of IGF-II receptors in the astrogliotic plaques
Part of this effect was related to a specific interaction with indicates that IGF-II receptors are not involved in the
IGF-II receptors, and suggested a role of IGF-II receptors mechanisms of astrogliosis.
in the differentiation of cholinergic neurons. Further
evidence for a role of IGF-II in the cholinergic neuro-
transmitter system was the observation that IGF-II poten-
1tiated the K -evoked release of acetylcholine from hip- Acknowledgements
pocampal slices [12]. Recently, Kang et al. [10] found that
retinoic acid also binds to the IGF-II receptor and sug- MS brain samples were obtained from the National
gested that the biological consequence of this interaction Neurological Research Specimen Bank, Los Angeles,
appears to be the suppression of cell proliferation and/or which is sponsored, among other organizations, by the
the induction of apoptosis. Studies in different neurode- National Multiple Sclerosis Society, and the Netherlands
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125Fig. 3. Autoradiographs of 0.1 nM [ I] IGF-II binding in the absence5total binding (T) and the presence of 0.5 mM unlabeled IGF-II5non-specific
binding (N) to microscope slide-mounted sections at the level of (A) frontal cortex (co) and white matter (wm), (B) caudate nucleus (cd) /putamen
(put)5neostriatum and nucleus accumbens (acc), (C) claustrum (clau), pallidium (pal) and putamen (put), (D) amygdala (am), (E) hippocampus: dentate
gyrus (dg) /pyramidal cell layer (pc), and para-hypocampal gyrus (pg), and (F) midbrain: substantia nigra (sn) /colliculus superior (cs) / red nucleus (rn) and
periaquaductal gray (pg). Bar51 cm.
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125Fig. 4. Autoradiographs of 0.1 nM [ I] IGF-II binding in the absence5total binding (T) and the presence of 0.5 mM unlabeled IGF-II5non-specific
binding (N) to microscope slide-mounted sections at the level of (A) pons: pontine nuclei (pn), (B) cerebellum: molecular layer (ml) /granular layer (gl),
white matter (wm), and (C) normal appearing white matter (wm), demyelinated astrogliotic plaque (p) and cerebral cortex (co) from a patient with multiple
sclerosis. Section (M) shows the myelin staining with luxol fast blue revealing a plaque (p). Bar51 cm.
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